This is actually unusual in the compounded GLP-1 space, where most providers increase pricing as doses escalate because higher doses require more active ingredient per vial
Who Should Be Cautious: Patients with a history of pancreatitis or gallbladder disease should discuss these conditions with their provider before starting either medication
In their questionnaire, which was used on every platorm, 98% asked about medical conditions, 93.9% asked about medications and allergies, and only 55.1% asked about eating disorder history
However, compounded semaglutide is not FDA-approved and should only be used under the supervision of a licensed provider
Most patients need to stay on a maintenance dose to keep their results
Osipova has been dedicated to treating both malignant and benign breast diseases, with a particular focus on the impact of hormones on breast tissue